Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
24118 | Emraclidine | 2170722-84-4 | 98% Min. | |
Emraclidine, also known as CVL-231 and PF-06852231, is a novel, brain-penetrant, high | ||||
24075 | EG-2184 | 2770297-66-8 | 98% Min. | |
24055 | E7046 | 1369489-71-3 | 98% Min. | |
E7046 is a potent and selective antagonist of the type 4 prostaglandin E2 (PGE2) rece | ||||
24032 | EPZ-719 | 2697176-16-0 | 98% Min. | |
20635 | ERAS-801 ( JGK-068S ) | 2490431-16-6 | ≧98.0% | |
ERAS-801 ( JGK-068S ) is a potent EGFR inhibitor. | ||||
20636 | Edecesertib | 2408839-73-4 | 98% Min. | |
Edecesertib is a serine/threonine kinase inhibitor and anti-inflammatory. Edecesertib | ||||
20607 | Ezurpimtrostat HCl | 1914148-73-4 | 98% Min. | |
Ezurpimtrostat is a palmitoyl protein thioesterase 1 (PPT-1) inhibitor. | ||||
20603 | EN460 | 496807-64-8 | 98% Min. | |
EN460 is an endoplasmic reticulum oxidoreductase (ERO1) inhibitor. EN460 showed a dos | ||||
20546 | (E)-4-Morpholinobut-2-enoic acid hydrochloride | 1419865-05-6 | 98% Min. | |
20523 | 1-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE | 304903-10-4 | 98% Min. | |
20480 | ethyl 5-chloro-6-fluoropyrazolo[1,5-a]pyrimidine-3-carboxylate | 2359650-50-1 | ≧96.0% | |
20449 | Ervogastat (PF-06865571) | 2186700-33-2 | ≧98.0% | |
Ervogastat (PF-06865571), a systemically acting diacylglycerol acyltransferase (DGAT2 | ||||
20447 | ELQ300 | 1354745-52-0 | 98% Min. | |
ELQ300 is a novel inhibitor of the mitochondrial cytochrome bc1 complex (complex III | ||||
20443 | Etrumadenant | 2239273- 34-6 | 98% Min. | |
Etrumadenant, also known as AB928, is a dual antagonist of the A2aR and A2bR adenosin | ||||
20436 | E6446 | 1219925-73-1 | 98% Min. | |
E6446 is a TLR inhibitor. E6446 inhibits Toll-like receptor (TLR)7 and 9 signaling. E | ||||
171455 | Etrumadenant | 2239273-34-6 | 98% Min. | |
Etrumadenant, also known as AB928, is a dual antagonist of the A2aR and A2bR adenosin | ||||
171652 | EZM0414 | 2411748-50-8 | ≧98.0% | |
EZM0414 is a potent, selective, and orally bioavailable inhibitor of SETD2. | ||||
20390 | ethyl 4,6-dihydroxypyridazine-3-carboxylate | 1352925-63-3 | 98% Min. | |
G20384 | 5-(Ethoxycarbonyl)-2-formyl-4-methyl-1H-pyrrole-3-propanoic Acid Methyl Ester | 54278-05-6 | 98% Min. | |
20366 | Ethyl 3-formyl-4-hydroxybenzoate | 82304-99-2 | 98% Min. | |
20365 | ethyl 3-bromo-4-ethoxy-5-formylbenzoate | 2701520-23-0 | 98% Min. | |
20360 | ethyl 4-hydroxy-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylate | 1443978-76-4 | 98% Min. | |
20359 | ethyl 4-chloro-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylate | 1449598-75-7 | 98% Min. | |
20358 | ethyl 4,6-dimethylpyrazolo[1,5-a]pyrazine-2-carboxylate | 1449598-76-8 | 98% Min. | |
20354 | Eribulin Mesylate | 441045-17-6 | 98% Min. | |
Eribulin is an anticancer drug marketed by Eisai Co. under the trade name Halaven. Er | ||||
20327 | Ethyl 4-Ethoxy-2-oxo-1,2-dihydropyridine-3-carboxylate | 1174046-84-4 | 96% Min. | |
20296 | Ecopipam hydrochloride ( SCH-39166 ) | 190133-94-9 | ≧98.0% | |
Ecopipam HCl is a Selective Dopamine Receptor D1/D5 Antagonist used in the treatment | ||||
20259 | Elinzanetant ( NT-814 ) | 929046-33-3 | ≧98.0% | |
Elinzanetant, previously known as NT-814 (45), is a dual NK1,3R antagonist and theref | ||||
16122809 | Elacestrant | 722533-56-4 | ≧98.0% | |
Elacestrant, also known as RAD1901, is an orally available, selective estrogen recept | ||||
21240 | E6446 | 1219925-73-1 | 98% Min. | |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2022 武汉永璨生物科技有限公司 版权所有 | 鄂ICP备17005301号-1